Metagenomi Reports Business Updates and Full Year 2023 Financial Results

Demonstrated nonhuman primate proof of concept in Hemophilia A program; progressing towards Development Candidate nomination by mid-year; 12-month nonhuman primate durability data in 2H 2024 Proof of...

Related Keywords

,Brianc Thomas ,Sarah Noonberg ,Luis Borges ,Simon Harnest ,Pamela Wapnick ,Ashlye Hodge ,Metagenomi Inc ,Securities Exchange ,Technology Platform ,Nasdaq ,Development Candidate ,Chief Executive Officer ,Program Highlights ,Transthyretin Amyloidosis ,Cardiovascular Disease ,Technology Platform Highlights ,Corporate Highlights ,Nasdaq Global Select Market ,Chief Medical Officer ,Chief Scientific Officer ,Chief Financial ,Consolidated Statements ,Ended December ,Note Regarding Forward ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Markets ,